Best Practices for Identification of Carbapenem Resistant Pseudomonas aeruginosa: An ASM-APHL- CDC Sponsored Training Webinar

Carbapenem Resistant Pseudomonas aeruginosa (CRPA) refers to carbapenem-resistant and carbapenemase-producing Pseudomonas aeruginosa. In 2010, carbapenemases known as metallo-β-lactamases (MBL) were first detected in the U.S.: New Delhi MBL (NDM) and Verona integron-encoded MBL (VIM). Currently, the most common type of carbapenemase seen in P. aeruginosa worldwide is VIM. The genes encoding carbapenemases are often located on plasmids that are easily spread between organisms. This webinar will discuss best practices for the laboratory identification of CRPA and the importance of communication between clinical labs and public health/labs about their test methods and results.

Eligibility

Continuing Education:
This webinar is approved for 1.0 P.A.C.E.® credit. ASM is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This presentation is recognized by the California Department of Health and Florida Department of Health and qualify for California and Florida CE credit toward license renewal.

Registration Details

Audience:
This basic level program is appropriate for all microbiologists working in clinical or public health laboratory settings.

Webinars Best Practices for Identification of Carbapenem Resistant Pseudomonas aeruginosa: An ASM-APHL- CDC Sponsored Training Webinar

Best Practices for Identification of Carbapenem Resistant Pseudomonas aeruginosa

Eligibility

Registration Details

Contact Information

Register for ASM Conference on Next-Generation Sequencing

Discover ASM membership

Get published in an ASM journal